| Product Code: ETC7231332 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 France Transdermal Patch Market Overview |
3.1 France Country Macro Economic Indicators |
3.2 France Transdermal Patch Market Revenues & Volume, 2021 & 2031F |
3.3 France Transdermal Patch Market - Industry Life Cycle |
3.4 France Transdermal Patch Market - Porter's Five Forces |
3.5 France Transdermal Patch Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 France Transdermal Patch Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 France Transdermal Patch Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in France leading to higher demand for transdermal patches. |
4.2.2 Growing elderly population in France requiring long-term medication management which can be facilitated by transdermal patches. |
4.2.3 Technological advancements in transdermal drug delivery systems driving innovation and adoption in the market. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of transdermal patches leading to longer time-to-market. |
4.3.2 Competition from alternative drug delivery methods such as oral medications or injections impacting the market growth. |
4.3.3 Concerns regarding skin irritation or allergic reactions associated with some transdermal patches affecting consumer acceptance. |
5 France Transdermal Patch Market Trends |
6 France Transdermal Patch Market, By Types |
6.1 France Transdermal Patch Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 France Transdermal Patch Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 France Transdermal Patch Market Revenues & Volume, By Methyl Salicylate-based Patch, 2021- 2031F |
6.1.4 France Transdermal Patch Market Revenues & Volume, By Rivastigmine Transdermal Patch, 2021- 2031F |
6.1.5 France Transdermal Patch Market Revenues & Volume, By Fentanyl Transdermal Patch, 2021- 2031F |
6.1.6 France Transdermal Patch Market Revenues & Volume, By Lidocaine Patch, 2021- 2031F |
6.1.7 France Transdermal Patch Market Revenues & Volume, By Diclofenac Patch, 2021- 2031F |
6.1.8 France Transdermal Patch Market Revenues & Volume, By Nicotine Transdermal Patch, 2021- 2031F |
6.2 France Transdermal Patch Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 France Transdermal Patch Market Revenues & Volume, By Rx Channel, 2021- 2031F |
6.2.3 France Transdermal Patch Market Revenues & Volume, By OTC Channel, 2021- 2031F |
7 France Transdermal Patch Market Import-Export Trade Statistics |
7.1 France Transdermal Patch Market Export to Major Countries |
7.2 France Transdermal Patch Market Imports from Major Countries |
8 France Transdermal Patch Market Key Performance Indicators |
8.1 Average time taken for regulatory approval of new transdermal patches in France. |
8.2 Number of new entrants and products introduced in the France transdermal patch market. |
8.3 Patient adherence rates to transdermal patch therapy in France. |
9 France Transdermal Patch Market - Opportunity Assessment |
9.1 France Transdermal Patch Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 France Transdermal Patch Market Opportunity Assessment, By Application, 2021 & 2031F |
10 France Transdermal Patch Market - Competitive Landscape |
10.1 France Transdermal Patch Market Revenue Share, By Companies, 2024 |
10.2 France Transdermal Patch Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |